Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.

Authors
Type
Published Article
Journal
Pancreas
0885-3177
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
42
Issue
3
Pages
511–515
Identifiers
DOI: 10.1097/MPA.0b013e31826c6aee
PMID: 23462324
Source
Medline
License
Unknown

Abstract

Gemcitabine in combination with capecitabine is effective and tolerable in unselected patients with APC, and outcomes are comparable with those of patients receiving GEMCAP in clinical trials.

Statistics

Seen <100 times